October 2020

Polsinelli is pleased to share the Health Care Reimbursement and Payor Dispute Update. This newsletter is a designated source of news, information and guidance on the constantly evolving reimbursement industry.

In This Issue:

  • States Move to Make Permanent COVID-19 Telehealth Waivers
  • Drug Manufacturers Unlawfully Target 340B Program Reductions
  • Catching Up on Recent Developments Surrounding CARES Act Stimulus Funds
  • The Intersection of State Escheatment Laws and Patient Credit Balances: Preparing for Increased State Action in the Era of COVID-19
  • Implementation of Evaluation and Management (“E/M”) Service Payment Creates Uncertainty for Medicare Professional Services Payment and Policy
  • What Other Reimbursement Changes Occurred While I Was Focused on COVID-19?
  • Gaps in Payment for COVID-19 Laboratory Testing Plague Providers and Patients
  • CMS Proposes Expanded Options for Determining “Reasonable and Necessary”
  • Value-Based Care Comes Full Circle: New CMS Guidance for Medicaid Programs

View the full newsletter here.